NewGenIvf Group Ltd financials

NIVF CIK 0001981662

Source: EDGAR filings · Built 2026-06-19T01:18:44Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Free Cash Flow -11.06M -8.32M -1.85M 1.60M 1.40M
EBITDA -10.54M -1.14M 73.42K 499.24K 365.47K
Working Capital 5.02M 452.39K 1.34M -157.03K
Net Debt 4.11M 5.46M 598.11K 826.12K
Gross Margin 20.22% 33.62% 32.74% 25.87% 24.88%
Operating Margin -226.95% -21.36% 0.82% 6.71% 4.83%
Net Margin 209.02% -9.66% 2.53% 7.72% -0.01%
Return on Equity (ROE) 37.10% 50.03% 3.49% 81.45% 0.06%
Return on Assets (ROA) 30.19% -14.66% 2.90% 15.79%
Current Ratio 3.12× 1.17× 2.19× 0.94×
Debt-to-Equity 0.18× -5.64× 0.17× 1.52×
Effective Tax Rate 50.66% 60.51% 188.70%
Cash Conversion Ratio -1.11× 15.75× -13.57× 3.73× -2688.56×
Accruals Ratio 0.64× 2.16× 0.42× -0.43×
SBC % of Revenue 4.04% 4.86%
CapEx Coverage -80.92× -138.91× -22.31× 15.02× 42.40×
Free Cash Flow Per Share $-3.40 $-69.95 $-184.53 $55.46 $2.50

Income Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Revenues 4.73M 5.43M 5.14M 5.94M 4.12M
Cost of Revenue 3.77M 3.61M 3.45M 4.41M 3.09M
Gross Profit 955.85K 1.83M 1.68M 1.54M 1.02M
Operating Expenses 11.68M 2.99M 1.64M 1.14M 826.02K
Operating Income (Loss) -10.73M -1.16M 42.24K 398.70K 198.76K
Income Tax Expense (Benefit) -486.71K 208.14K 294.72K
Net Income (Loss) Attributable to Parent 9.88M -524.64K 130.19K 458.67K -533
Earnings Per Share, Basic $214.73 $-4408.76 $13019.30 $4.72 $0.00
Weighted Average Number of Shares Outstanding, Basic 46,009 119 10 28,797 560,000
Earnings Per Share, Diluted $3.04 $-4408.76 $13019.30 $4.72 $0.00
Weighted Average Number of Shares Outstanding, Diluted 3.25M 119,000 10,000 28,797 560,000

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Cash and Cash Equivalents, at Carrying Value 758.62K 457.74K 54.10K 27.56K
Assets, Current 7.38M 3.17M 2.46M 2.40M
Assets 32.72M 3.58M 4.49M 2.90M
Liabilities, Current 2.37M 2.72M 1.12M 2.56M
Liabilities 6.74M 5.06M 1.24M 2.80M
Stockholders' Equity Attributable to Parent 26.63M -1.05M 3.74M 563.11K
Common Stock, Shares, Outstanding 240,622 380,000 507,469 601,830

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2023
Net Cash Provided by (Used in) Operating Activities -10.93M -8.26M -1.77M 1.71M 1.43M
Payments to Acquire Property, Plant, and Equipment 135.03K 53.05K 69.85K 94.45K 16.57K
Net Cash Provided by (Used in) Investing Activities -7.56M -53.05K -69.85K -94.45K -16.57K
Net Cash Provided by (Used in) Financing Activities 18.99M 8.68M 1.88M -1.63M -1.54M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (NIVF CIK 0001981662), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RYZ

Ryerson Holding Corp

BCIC

BCP Investment Corporation

ICU

SeaStar Medical Holding Corp